---
title: "MicroTech Medical (Hangzhou) Co., Ltd. (02235.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02235.HK.md"
symbol: "02235.HK"
name: "MicroTech Medical (Hangzhou) Co., Ltd."
industry: "Health Care Equipment"
---

# MicroTech Medical (Hangzhou) Co., Ltd. (02235.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Location | HK Market |
| Website | [www.microtechmd.com](https://www.microtechmd.com) |

## Company Profile

MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:09.000Z

**Overall: C (0.42)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 19 / 26 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 50.53% |  |
| Net Profit YoY | 80.76% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.42 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.07B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 477.83M |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -1.39% | D |
| Profit Margin | -6.28% | D |
| Gross Margin | 51.66% | B |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 50.53% | A |
| Net Profit YoY | 80.76% | A |
| Total Assets YoY | 3.73% | C |
| Net Assets YoY | -0.32% | D |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1592.48% | E |
| OCF YoY | 50.53% | A |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.20 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 10.80% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - MicroTech Medical (Hangzhou) Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-1.39%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-6.28%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "51.66%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "50.53%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "80.76%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "3.73%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.32%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1592.48%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "50.53%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.20",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "10.80%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | ANGELALIGN (HK.6699) | B | A | C | B | B | B |
| 02 | ZYLOXTB (HK.2190) | B | A | D | A | B | B |
| 03 | AK MEDICAL (HK.1789) | B | A | C | B | B | B |
| 04 | SCIENTECH (HK.2291) | A | B | D | A | B | B |
| 05 | MODERN DENTAL (HK.3600) | A | B | B | B | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -101.15 | 26/27 | - | - | - |
| PB | 1.42 | 8/27 | 1.48 | 1.32 | 1.18 |
| PS (TTM) | 6.35 | 15/27 | 7.32 | 6.75 | 6.28 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-07T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.35 |
| Highest Target | 7.40 |
| Lowest Target | 7.40 |

## References

- [Company Overview](https://longbridge.com/en/quote/02235.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02235.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02235.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.